Recent advances in clinical development of leukotriene B4 pathway drugs-Reference-Cited by-同舟云学术

Recent advances in clinical development of leukotriene B4 pathway drugs

Published:2017-10 Issue: Volume:33 Page:65-73
ISSN:1044-5323
Container-title:Seminars in Immunology
language:en
Short-container-title:Seminars in Immunology

Author:

Bhatt L.,Roinestad K.,Van T.,Springman E.B.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference85 articles.

1. Leukotriene B4 receptors: novel roles in immunological regulations;Yokomizo;Adv. Enzyme Reg.,2001

2. 12(S)-hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2;Okuno;J. Exp. Med.,2008

3. Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis;Iizuku;FASEB J.,2010

4. Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia;Matsunaga;FASEB J.,2013

5. LY293111 inhibits tumor cell growth cell growth in vitro through an apparent PPARgamma agonist activity;Marshall;Proceedings 93rd Annual Meeting of American Association for Cancer Research (AACR ‘02),2002

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring montelukast in dogs: A preliminary pharmacokinetic study following oral administration under fasted and fed conditions;The Veterinary Journal;2024-10

2. Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment;Biomedicines;2024-08-16

3. Cystic fibrosis management in pediatric population—from clinical features to personalized therapy;Frontiers in Pediatrics;2024-05-10

4. Structure-Guided Elaboration of a Fragment-Like Hit into an Orally Efficacious Leukotriene A4 Hydrolase Inhibitor;Journal of Medicinal Chemistry;2024-03-13

5. Metabolomics unveils the exacerbating role of arachidonic acid metabolism in atherosclerosis;Frontiers in Molecular Biosciences;2024-02-07